Palliative resection of the primary tumor in 442 metastasized neuroendocrine tumors of the pancreas: a population-based, propensity score-matched survival analysis

There is an ongoing debate on whether palliative removal of the primary tumor may result in a survival benefit for patients with incurable stage IV pancreatic neuroendocrine tumors (P-NET). The objective of this study was to assess whether palliative resection of the primary tumor in patients with i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hüttner, Felix (VerfasserIn) , Schneider, Lutz (VerfasserIn) , Tarantino, Ignazio (VerfasserIn) , Warschkow, René (VerfasserIn) , Schmied, Bruno (VerfasserIn) , Hackert, Thilo (VerfasserIn) , Diener, Markus K. (VerfasserIn) , Büchler, Markus W. (VerfasserIn) , Ulrich, Alexis (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 22 July 2015
In: Langenbeck's archives of surgery
Year: 2015, Jahrgang: 400, Heft: 6, Pages: 715-723
ISSN:1435-2451
DOI:10.1007/s00423-015-1323-x
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00423-015-1323-x
Volltext
Verfasserangaben:Felix J. Hüttner, Lutz Schneider, Ignazio Tarantino, Rene Warschkow, Bruno M. Schmied, Thilo Hackert, Markus K. Diener, Markus W. Büchler, Alexis Ulrich
Beschreibung
Zusammenfassung:There is an ongoing debate on whether palliative removal of the primary tumor may result in a survival benefit for patients with incurable stage IV pancreatic neuroendocrine tumors (P-NET). The objective of this study was to assess whether palliative resection of the primary tumor in patients with incurable stage IV P-NET has an impact on survival.
Beschreibung:Gesehen am 03.06.2020
Beschreibung:Online Resource
ISSN:1435-2451
DOI:10.1007/s00423-015-1323-x